Page last updated: 2024-09-03

s 20928 and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

s 20928 has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies

Compound Research Comparison

Studies
(s 20928)
Trials
(s 20928)
Recent Studies (post-2010)
(s 20928)
Studies
(15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
Trials
(15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
Recent Studies (post-2010) (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
17002,57727327

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delagrange, P; O'Rourke, ST; Scalbert, E; Vanhoutte, PM; Yang, Q1
Delagrange, P; Hammad, H; O'Rourke, ST; Scalbert, E; Vanhoutte, PM1

Other Studies

2 other study(ies) available for s 20928 and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

ArticleYear
Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Vessels; Drug Synergism; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Melatonin; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Serotonin; Swine; Vasoconstrictor Agents; Vasodilator Agents

2001
Melatonin inhibits nitrate tolerance in isolated coronary arteries.
    British journal of pharmacology, 2003, Volume: 139, Issue:7

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteries; Coronary Vessels; Cromakalim; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Isometric Contraction; Isoproterenol; Melatonin; Muscle, Smooth, Vascular; Naphthalenes; Nitrates; Nitroglycerin; Receptors, Melatonin; Swine; Tachyphylaxis; Time Factors; Tryptamines; Vasoconstriction; Vasodilation; Vasodilator Agents

2003